Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
1.840
+0.090 (5.14%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $51.01 million as of April 25, 2025. Its market cap has decreased by -32.90% in one year.
Market Cap
51.01M
Enterprise Value
34.40M
1-Year Change
-32.90%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has decreased from $65.74M to $51.01M, a decrease of -22.41%. That is a compound annual growth rate of -7.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 51.84M | -14.34% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 764.11B |
| UnitedHealth Group | 387.77B |
| Johnson & Johnson | 372.39B |
| AbbVie | 317.43B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 224.54B |
| AstraZeneca | 213.42B |
| Novartis AG | 208.99B |